Draper, Kenneth G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Draper, Kenneth G..The latest application filed is for "method and reagent for treatment of diseases caused by expression of the c-myc gene".
- Draper, Kenneth G. - Reno NV
- Draper, Kenneth G. - Boulder CO
- Draper; Kenneth G. - San Marcos CA
- Draper; Kenneth G. - Solon OH
- Draper; Kenneth G. - Richmond OH
- Draper; Kenneth G. - Madison NJ
| Patent | Date |
|---|---|
| Method and reagent for treatment of diseases caused by expression of the c-myc gene App 20040033568 - Thompson, James D. ; et al. | 2004-02-19 |
| Method and reagent for treatment of diseases caused by expression of the c-myc gene App 20030162264 - Thompson, James D. ; et al. | 2003-08-28 |
| Ribozyme treatment of diseases or conditions related to levels of NF-kappaB App 20030003469 - Stinchcomb, Dan T. ; et al. | 2003-01-02 |
| Enzymatic nucleic acid treatment of diseases or conditions related to levels of NF-kappa B App 20020177568 - Stinchcomb, Dan T. ; et al. | 2002-11-28 |
| Ribozyme treatment of diseases or conditions related to levels of NF-.kappa.B Grant 6,410,224 - Stinchcomb , et al. June 25, 2 | 2002-06-25 |
| Oligonucleotide therapies for modulating the effects of herpesviruses Grant 6,310,044 - Draper , et al. October 30, 2 | 2001-10-30 |
| Composition and method for treatment of CMV infections Grant 6,153,595 - Draper , et al. November 28, 2 | 2000-11-28 |
| HIV nef targeted ribozymes Grant 5,972,704 - Draper , et al. October 26, 1 | 1999-10-26 |
| Method and reagent for inhibiting hepatitis C virus replication Grant 5,869,253 - Draper February 9, 1 | 1999-02-09 |
| Intercellular adhesion molecule-1 (ICAM-1) ribozymes Grant 5,837,542 - Grimm , et al. November 17, 1 | 1998-11-17 |
| Antisense composition and method for treatment of CMV infection Grant 5,767,102 - Draper , et al. June 16, 1 | 1998-06-16 |
| Method and reagent for treatment of diseases caused by expression of the bcl-2 gene Grant 5,750,390 - Thompson , et al. May 12, 1 | 1998-05-12 |
| HIV targeted ribozymes Grant 5,693,535 - Draper , et al. December 2, 1 | 1997-12-02 |
| Rel a targeted ribozymes Grant 5,658,780 - Stinchcomb , et al. August 19, 1 | 1997-08-19 |
| Oligonucleotide therapies for modulating the effects of herpesviruses Grant 5,658,891 - Draper , et al. August 19, 1 | 1997-08-19 |
| PML-RARA targeted ribozymes Grant 5,639,655 - Thompson , et al. June 17, 1 | 1997-06-17 |
| Method and reagent for inhibiting T-cell leukemia virus replication Grant 5,622,854 - Draper April 22, 1 | 1997-04-22 |
| Ribozymes targeted to TNF-.alpha. RNA Grant 5,616,490 - Sullivan , et al. April 1, 1 | 1997-04-01 |
| IL-5 targeted ribozymes Grant 5,616,488 - Sullivan , et al. April 1, 1 | 1997-04-01 |
| Stromelysin targeted ribozymes Grant 5,612,215 - Draper , et al. March 18, 1 | 1997-03-18 |
| Enzymatic RNA molecule targeted against Hepatitis C virus Grant 5,610,054 - Draper March 11, 1 | 1997-03-11 |
| Enzymatic RNA with activity to ras Grant 5,610,052 - Thompson , et al. March 11, 1 | 1997-03-11 |
| ErbB2/neu targeted ribozymes Grant 5,599,704 - Thompson , et al. February 4, 1 | 1997-02-04 |
| Oligonucleotides for modulating the effects of cytomegalovirus infections Grant 5,591,720 - Anderson , et al. January 7, 1 | 1997-01-07 |
| Oligonucleotide therapies for modulating the effects of herpes viruses Grant 5,514,577 - Draper , et al. May 7, 1 | 1996-05-07 |
| Method of isolating ribozyme targets Grant 5,496,698 - Draper , et al. March 5, 1 | 1996-03-05 |
| Antisense oligonucleotides for inhibiting herpesviruses Grant 5,248,670 - Draper , et al. September 28, 1 | 1993-09-28 |
| Antiviral oligomers Grant 5,004,810 - Draper April 2, 1 | 1991-04-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 